孟佩多酸用于对他类药物不耐受患者的心血管事件的初级预防
在PubMed上查看摘要
概括
此摘要是机器生成的。在没有先前心血管事件的他类药物不耐受患者中,佩多酸显著降低了心血管事件. 这种药物提供了一种新的初级预防方案,
科学领域
- 心脏病学
- 药理学
- 临床试验
背景情况
- 对于他类药物不耐受的患者需要替代性降脂疗法.
- 在初级预防中,降低心血管风险至关重要.
研究的目的
- 评估bempedoic酸在初级预防不耐受他类药物的患者中减少心血管事件的有效性.
主要方法
- 一个随机,双盲,安慰剂对照的试验.
- 包括13,970名他类药物不耐受患者,其中4,206名患者接受初级预防治疗.
- 参与者接受了白酸 (每天180毫克) 或安慰剂,平均时间为39. 9个月.
主要成果
- 孟佩多酸降低了 21. 3% 的LDL胆固醇和 21. 5% 的hsCRP.
- 观察到主要复合终点 (心血管死亡,心脏病发作,中风,再血管) 的显著降低 (HR,0. 70).
- 关键的二次终点,包括心脏病发作和心血管死亡,也显著降低了风险.
结论
- 在高风险的初级预防患者中,白酸有效降低了对他类药物不耐受性的心血管事件.
- 它为这一群体提供了可行的治疗选择.
- 这些不良反应包括痛风和胆结石病的发病率增加.
相关概念视频
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...

